Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for MASI
27.00
0.00 (0.00%)
Dec 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 19.30 - 32.20
Open     -
Vol / Avg. 0.00/401,699.00
Mkt cap 1.42B
P/E 25.30
Div/yield     -
EPS 1.07
Shares 52.41M
Beta 0.83
Inst. own 84%
Feb 11, 2015
Q4 2014 Masimo Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 2, 2014
Masimo Corp at Piper Jaffray Healthcare Conference - Webcast
Oct 29, 2014
Q3 2014 Masimo Corp Earnings Call - Webcast
Oct 29, 2014
Q3 2014 Masimo Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 11.19% 10.18%
Operating margin 15.45% 14.57%
EBITD margin - 18.12%
Return on average assets 12.55% 13.70%
Return on average equity 19.79% 19.48%
Employees 3,139 -
CDP Score - -

Address

40 PARKER
IRVINE, CA 92618
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation, is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. In addition, the Company offers remote alarm/monitoring solutions and software. The Company�s Masimo Signal Extraction Technology (Masimo SET) provides the capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Masimo SET has been validated in over 100 independent clinical studies. In May 2014, the Company's subsidiary purchased land and a 213,800 square foot building located in Irvine, California from Nikken, Inc.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 50
Bio & Compensation  - Reuters
Rick Fishel President - Worldwide OEM Business and Corporate Development
Age: 56
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Marketing and Clinical Development
Age: 43
Bio & Compensation  - Reuters
Yongsam Lee Chief Information Officer
Age: 49
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 69
Bio & Compensation  - Reuters
Robert L. Coleman Ph.D. Independent Director
Age: 68
Bio & Compensation  - Reuters